{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:11:26Z","timestamp":1791882686169,"version":"4.3.4"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,24]]},"DOI":"10.1097\/qad.0b013e32833bedeb","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T00:22:44Z","timestamp":1280794964000},"page":"1975-1982","source":"Crossref","is-referenced-by-count":80,"title":["Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation"],"prefix":"10.1097","volume":"24","author":[{"given":"Lynn T","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Celum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Bangsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/157016207781023992","article-title":"HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy","volume":"5","author":"Guthrie","year":"2007","journal-title":"Curr HIV Res"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(08)60953-8","article-title":"New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data","volume":"371","author":"Dunkle","year":"2008","journal-title":"Lancet"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10461-009-9551-0","article-title":"Strategies for harm reduction among HIV-affected couples who want to conceive","volume":"13","author":"Matthews","year":"2009","journal-title":"AIDS Behav"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.fertnstert.2005.07.1326","article-title":"Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply","volume":"85","author":"Frodsham","year":"2006","journal-title":"Fertil Steril"},{"key":"R7-1-20210130","first-page":"124","article-title":"High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner: two challenging issues","volume":"133","author":"Panozzo","year":"2003","journal-title":"Swiss Med Wkly"},{"issue":"Suppl 1","key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.aids.0000255089.44297.6f","article-title":"Reproductive choice in men and women living with HIV: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA Study)","volume":"21","author":"Heard","year":"2007","journal-title":"AIDS"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/apc.2006.0108","article-title":"Prevalence and determinants of fertility intentions of HIV-infected women and men receiving antiretroviral therapy in South Africa","volume":"21","author":"Myer","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11904-006-0015-0","article-title":"The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa","volume":"3","author":"Kaida","year":"2006","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"Suppl 1","key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10461-008-9371-7","article-title":"Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda","volume":"13","author":"Maier","year":"2009","journal-title":"AIDS Behav"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/humrep\/17.6.1663","article-title":"Men leave me as I cannot have children': women's experiences with involuntary childlessness","volume":"17","author":"Dyer","year":"2002","journal-title":"Hum Reprod"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/humrep\/deh845","article-title":"Psychological distress among women suffering from infertility in South Africa: a quantitative assessment","volume":"20","author":"Dyer","year":"2005","journal-title":"Hum Reprod"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/humrep\/den141","article-title":"Involuntary childlessness: a neglected problem in poor-resource areas","volume":"1","author":"Van Balen","year":"2008","journal-title":"ESHRE Monogr"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ije\/29.2.285","article-title":"Primary and secondary infertility in sub-Saharan Africa","volume":"29","author":"Larsen","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1521\/aeap.2008.20.6.531","article-title":"The unintended consequences of intended pregnancies: youth, condom use, and HIV transmission in Mozambique","volume":"20","author":"Speizer","year":"2008","journal-title":"AIDS Educ Prev"},{"key":"R18-1-20210130","first-page":"397","article-title":"Fertility and culture in Sub-Saharan Africa: a review","volume":"46","author":"Sonko","year":"1994","journal-title":"Int Soc Sci J"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.qai.0000243091.40490.fd","article-title":"Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy","volume":"43","author":"Barreiro","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/QAD.0b013e32830abdc8","article-title":"Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma","volume":"22","author":"Marcelin","year":"2008","journal-title":"AIDS"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/QAD.0b013e3282703879","article-title":"Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network","volume":"21","author":"Bujan","year":"2007","journal-title":"AIDS"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.pctr.0020027","article-title":"Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00042560-200205010-00010","article-title":"Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania","volume":"30","author":"Hugonnet","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.qai.0000286597.57066.2b","article-title":"Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing","volume":"46","author":"Girardi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(00)02447-8","article-title":"Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania","volume":"356","author":"Sweat","year":"2000","journal-title":"Lancet"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00002030-200303280-00012","article-title":"Sexual behavior of HIV discordant couples after HIV counseling and testing","volume":"17","author":"Allen","year":"2003","journal-title":"AIDS"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/bmj.304.6842.1605","article-title":"Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa","volume":"304","author":"Allen","year":"1992","journal-title":"BMJ"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10461-009-9592-4","article-title":"Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe","volume":"14","author":"Cremin","year":"2010","journal-title":"AIDS Behav"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2458-7-349","article-title":"Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities","volume":"7","author":"Allen","year":"2007","journal-title":"BMC Public Health"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042560-200203010-00001","article-title":"Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta)","volume":"29","author":"Tarantal","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00350-08","article-title":"Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects","volume":"52","author":"Van Rompay","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1345\/aph.1L083","article-title":"Adverse effects of tenofovir use in HIV-infected pregnant women and their infants","volume":"42","author":"Nurutdinova","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1371\/journal.pmed.0030454","article-title":"Criteria for drugs used in preexposure prophylaxis trials against HIV infection","volume":"3","author":"Derdelinckx","year":"2006","journal-title":"PLoS Med"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00002030-200207050-00008","article-title":"The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study","volume":"16","author":"Laurent","year":"2002","journal-title":"AIDS"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jama.296.6.679","article-title":"Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis","volume":"296","author":"Mills","year":"2006","journal-title":"JAMA"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-200306130-00011","article-title":"Adherence is not a barrier to successful antiretroviral therapy in South Africa","volume":"17","author":"Orrell","year":"2003","journal-title":"AIDS"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"R50-1-20210130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(07)60950-7","article-title":"Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial","volume":"370","author":"Padian","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/01.qai.0000137005.63376.6e","article-title":"Resistance issues with new nucleoside\/nucleotide backbone options","volume":"37","author":"Wainberg","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R53-1-20210130","first-page":"22","article-title":"K65R, TAMs and tenofovir","volume":"6","author":"Miller","year":"2004","journal-title":"AIDS Rev"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1086\/597804","article-title":"Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe","volume":"199","author":"van de Vijver","year":"2009","journal-title":"J Infect Dis"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/597095","article-title":"HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness","volume":"48","author":"Paltiel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1371\/journal.pone.0000875","article-title":"Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings","volume":"2","author":"Abbas","year":"2007","journal-title":"PLoS One"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11904-007-0024-7","article-title":"Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies","volume":"4","author":"Eaton","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"e2077","DOI":"10.1371\/journal.pone.0002077","article-title":"The impact of preexposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study","volume":"3","author":"Vissers","year":"2008","journal-title":"PLoS ONE"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.qai.0000143600.41363.78","article-title":"HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial","volume":"39","author":"Bartholow","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002030-200401230-00020","article-title":"Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B\/E HIV vaccine trial in Bangkok, Thailand","volume":"18","author":"van Griensvan","year":"2004","journal-title":"AIDS"},{"key":"R62-1-20210130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-146-8-200704170-00010","article-title":"Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1","volume":"146","author":"Cohen","year":"2007","journal-title":"Ann Intern Med"},{"key":"R63-1-20210130","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/OLQ.0b013e3181812939","article-title":"Changes in sexual risk behavior among participants in a PrEP HIV prevention trial","volume":"35","author":"Guest","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R65-1-20210130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00002030-200201250-00011","article-title":"The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis","volume":"16","author":"Sadiq","year":"2002","journal-title":"AIDS"},{"key":"R66-1-20210130","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"R69-1-20210130","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.pmed.0050157","article-title":"Prevention of SIV rectal transmission and priming of T cell responses in macaques after local preexposure application of tenofovir gel","volume":"5","author":"Cranage","year":"2008","journal-title":"PLoS Med"},{"key":"R70-1-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.aids.0000210608.70762.c3","article-title":"Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women","volume":"20","author":"Mayer","year":"2006","journal-title":"AIDS"},{"key":"R71-1-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jwh.2006.0325","article-title":"Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study","volume":"17","author":"Rosen","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R73-1-20210130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/318829","article-title":"Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study","volume":"183","author":"Kahn","year":"2001","journal-title":"J Infect Dis"},{"key":"R74-1-20210130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/QAI.0b013e318162afcb","article-title":"Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center","volume":"47","author":"Mayer","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R75-1-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0b013e318198a96a","article-title":"The structure and outcomes of a HIV postexposure prophylaxis program in a high HIV prevalence setup in western Kenya","volume":"51","author":"Siika","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R78-1-20210130","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"R79-1-20210130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":"Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R80-1-20210130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R81-1-20210130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda","volume":"191","author":"Wawer","year":"2005","journal-title":"J Infect Dis"},{"key":"R82-1-20210130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(05)61754-0","article-title":"Natural conception in HIV-negative women with HIV-infected partners","volume":"349","author":"Mandelbrot","year":"1997","journal-title":"Lancet"},{"key":"R83-1-20210130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(95)91380-7","article-title":"Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial","volume":"346","author":"Grosskurth","year":"1995","journal-title":"Lancet"},{"key":"R84-1-20210130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/00002030-199810000-00014","article-title":"A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda","volume":"12","author":"Wawer","year":"1998","journal-title":"AIDS"},{"key":"R85-1-20210130","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0040102","article-title":"Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in Eastern Zimbabwe","volume":"4","author":"Gregson","year":"2007","journal-title":"PLoS Med"},{"key":"R86-1-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(03)12598-6","article-title":"Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial","volume":"361","author":"Kamali","year":"2003","journal-title":"Lancet"},{"key":"R87-1-20210130","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1001\/jama.291.21.2555","article-title":"Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers","volume":"291","author":"Kaul","year":"2004","journal-title":"JAMA"},{"key":"R88-1-20210130","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/425274","article-title":"Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials","volume":"191","author":"Korenromp","year":"2005","journal-title":"J Infect Dis"},{"key":"R89-1-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(98)06439-3","article-title":"Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial","volume":"353","author":"Wawer","year":"1999","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201008240-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:29:18Z","timestamp":1786040958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201008240-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":69,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833bedeb","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}